Expertise in
4
conditions

Pieter Dewint

CHU UCL Namur
Yvoir, WAL, BE 
Expertise in
4
conditions
CHU UCL Namur
Yvoir, WAL, BE 

Overview

Pieter Dewint practices practicing medicine in Yvoir, Belgium.

Mr. Dewint is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Anal Fissure, Viral Gastroenteritis, Peutz-Jeghers Syndrome, Endoscopy, and Hemorrhoidectomy.

He is actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

CHU UCL Namur
Yvoir, WAL, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multicentric, Double-blind, Placebo Controlled Clinical Trial With 5-hydroxytryptophan (5-HTP) in Patients With Inflammatory Bowel Disease in Clinical and Biologic Remission: Effect on Fatigue Scores
Multicentric, Double-blind, Placebo Controlled Clinical Trial With 5-hydroxytryptophan (5-HTP) in Patients With Inflammatory Bowel Disease in Clinical and Biologic Remission: Effect on Fatigue Scores
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Drug
Study Drug: 5-HTP
Study Phase: Phase 2
Evaluation of the Safety and Effectiveness of Switching From Originator (Humira®) to Biosimilar (Imraldi®) Adalimumab in Flanders (SafE-OrBi)
Evaluation of the Safety and Effectiveness of Switching From Originator (Humira®) to Biosimilar (Imraldi®) Adalimumab in Flanders (SafE-OrBi)
Enrollment Status: Completed
Publish Date: April 27, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

31 Total Publications

The Effect of Dose Intensification After Secondary Loss of Response to Ustekinumab in Crohn's Disease: Results of the REScUE Study.
The Effect of Dose Intensification After Secondary Loss of Response to Ustekinumab in Crohn's Disease: Results of the REScUE Study.
Journal: Gastroenterology
Published: September 13, 2025

Frequently Asked Questions about Pieter Dewint

Is Pieter Dewint a top-rated expert for Anal Fissure?

MediFind is an objective health platform that identifies experts based on real-world data. Pieter Dewint is classified as an Advanced expert for Anal Fissure, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pieter Dewint participate in research or clinical trials?

Yes. Pieter Dewint has published 31 articles and abstracts on conditions like Anal Fissure. You can view a list of Pieter Dewint's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dewint's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile